What is Deepverge?
Founded in 2016 and based in Malahide, Ireland, Deepverge operates as a vertically integrated company that bridges physical and cloud-based AI test services. Its core focus is on commercializing advanced AI solutions for the detection of bacteria in critical sectors such as skincare, healthcare, and water quality monitoring. The company's Labskin platform is a scientifically validated test service designed to prove the efficacy of skincare product claims, serving a diverse clientele across the healthcare, life sciences, clinical research, pharmaceutical, and cosmetics industries. This strategic positioning allows Deepverge to address growing demands for verifiable product performance and safety.
How much funding has Deepverge raised?
Deepverge has raised a total of $14.2M across 1 funding round:
Share Placement
$14.2M
Share Placement (2021): $14.2M, investors not publicly disclosed
What's next for Deepverge?
The recent major strategic investment signals a pivotal moment for Deepverge, likely enabling the company to accelerate its market penetration and further develop its AI-driven diagnostic capabilities. With enterprise-level funding, Deepverge is poised to scale its operations, enhance its technological infrastructure, and potentially expand its service offerings into new verticals or geographical markets. This capital infusion is expected to fuel innovation in its AI test services, reinforcing its commitment to providing robust solutions for bacteria detection and product claim validation in high-stakes industries.
See full Deepverge company page
